Income Statement

Revenue

+54%

+93%

10Y

Currency: KRW

	Dec-2004	Mar-2005	Jun-2005	Sep-2005	Dec-2005	Mar-2006	Jun-2006	Sep-2006	Dec-2006	Mar-2007	Jun-2007	Sep-2007	Dec-2007	Mar-2008	Jun-2008	Sep-2008	Dec-2008	Mar-2009	Jun-2009	Sep-2009	Dec-2009	Mar-2010	Jun-2010	Sep-2010	Dec-2010	Mar-2011	Jun-2011	Sep-2011	Dec-2011	Mar-2012	Jun-2012	Sep-2012	Dec-2012	Mar-2013	Jun-2013	Sep-2013	Dec-2013	Mar-2014	Jun-2014	Sep-2014	Dec-2014	Mar-2015	Jun-2015	Sep-2015	Dec-2015	Mar-2016	Jun-2016	Sep-2016	Dec-2016	Mar-2017	Jun-2017	Sep-2017	Dec-2017	Mar-2018	Jun-2018	Sep-2018	Dec-2018	Mar-2019	Jun-2019	Sep-2019	Dec-2019	Mar-2020	Jun-2020	Sep-2020	Dec-2020	Mar-2021	Jun-2021	Sep-2021	Dec-2021	Mar-2022	Jun-2022	Sep-2022	Dec-2022	Mar-2023	Jun-2023	Sep-2023	Dec-2023	Mar-2024	Jun-2024	Sep-2024	Dec-2024	Mar-2025	Jun-2025	Sep-2025
Revenue
Interest Expense	6	6	6	7	5	5	5	5	5	5	11	31	69	107	210	267	335	512	577	794	637	0	0	0	387	0	0	0	916	240	0	0	934	218	395	0	854	287	264	391	525	534	504	528	630	737	847	907	885	872	839	759	822	712	761	796	706	801	825	933	1 035	1 102	1 090	993	757	579	0	177	117	91	126	133	160	180	181	163	143	632	1 416	2 212	3 002	0	0	0
Revenue	46 606 N/A	47 169 +1%	51 998 +10%	53 919 +4%	58 480 +8%	60 438 +3%	60 474 +0%	61 698 +2%	61 110 -1%	63 342 +4%	62 035 -2%	63 381 +2%	64 128 +1%	66 295 +3%	71 217 +7%	70 794 -1%	75 910 +7%	78 123 +3%	82 290 +5%	90 439 +10%	100 530 +11%	102 434 +2%	106 916 +4%	109 093 +2%	112 796 +3%	117 411 +4%	119 647 +2%	123 628 +3%	129 946 +5%	135 248 +4%	140 620 +4%	144 132 +2%	140 828 -2%	147 964 +5%	151 756 +3%	154 221 +2%	153 972 0%	152 905 -1%	154 379 +1%	161 702 +5%	167 936 +4%	173 784 +3%	181 973 +5%	185 568 +2%	197 736 +7%	195 871 -1%	188 194 -4%	183 924 -2%	174 002 -5%	176 178 +1%	179 048 +2%	182 032 +2%	183 600 +1%	179 556 -2%	177 601 -1%	177 662 +0%	185 746 +5%	179 167 -4%	173 064 -3%	167 393 -3%	155 852 -7%	158 870 +2%	160 059 +1%	156 318 -2%	143 364 -8%	141 127 -2%	143 734 +2%	149 137 +4%	163 534 +10%	175 163 +7%	182 760 +4%	195 740 +7%	205 389 +5%	213 414 +4%	224 219 +5%	226 186 +1%	233 676 +3%	244 223 +5%	252 480 +3%	264 636 +5%	271 116 +2%	281 128 +4%	290 775 +3%	300 958 +4%
Gross Profit
Cost of Revenue	(12 549)	(13 345)	(13 905)	(14 733)	(15 528)	(16 047)	(16 775)	(16 635)	(17 026)	(17 513)	(17 755)	(19 195)	(21 121)	(22 363)	(23 864)	(23 502)	(25 150)	(26 074)	(27 849)	(32 371)	(37 506)	(37 823)	(40 653)	(42 169)	(46 801)	(50 913)	(53 260)	(56 866)	(64 953)	(68 893)	(74 175)	(77 599)	(78 859)	(84 246)	(88 946)	(89 553)	(85 038)	(86 690)	(86 371)	(91 231)	(98 163)	(101 925)	(104 785)	(107 477)	(116 626)	(115 723)	(114 812)	(114 573)	(103 616)	(102 580)	(98 716)	(95 290)	(91 423)	(85 400)	(84 171)	(84 365)	(87 959)	(82 680)	(78 264)	(75 069)	(77 858)	(73 503)	(73 393)	(68 436)	(58 471)	(57 025)	(58 285)	(59 473)	(62 516)	(67 849)	(70 574)	(75 199)	(79 109)	(80 640)	(85 173)	(86 870)	(93 105)	(99 411)	(100 810)	(105 196)	(103 219)	(104 106)	(106 113)	(106 184)
Gross Profit	34 057 N/A	33 823 -1%	38 092 +13%	39 185 +3%	42 952 +10%	44 391 +3%	43 699 -2%	45 063 +3%	44 084 -2%	45 829 +4%	44 280 -3%	44 186 0%	43 008 -3%	43 932 +2%	47 353 +8%	47 292 0%	50 761 +7%	52 049 +3%	54 441 +5%	58 068 +7%	63 023 +9%	64 611 +3%	66 263 +3%	66 924 +1%	65 995 -1%	66 499 +1%	66 387 0%	66 762 +1%	64 993 -3%	66 354 +2%	66 445 +0%	66 532 +0%	61 969 -7%	63 717 +3%	62 809 -1%	64 668 +3%	68 934 +7%	66 215 -4%	68 008 +3%	70 471 +4%	69 774 -1%	71 859 +3%	77 188 +7%	78 091 +1%	81 110 +4%	80 148 -1%	73 382 -8%	69 351 -5%	70 386 +1%	73 598 +5%	80 331 +9%	86 741 +8%	92 177 +6%	94 156 +2%	93 430 -1%	93 297 0%	97 786 +5%	96 486 -1%	94 800 -2%	92 323 -3%	77 994 -16%	85 367 +9%	86 666 +2%	87 883 +1%	84 893 -3%	84 102 -1%	85 449 +2%	89 664 +5%	101 018 +13%	107 314 +6%	112 186 +5%	120 541 +7%	126 279 +5%	132 774 +5%	139 047 +5%	139 316 +0%	140 571 +1%	144 811 +3%	151 669 +5%	159 440 +5%	167 896 +5%	177 022 +5%	184 661 +4%	194 774 +5%
Operating Income
Operating Expenses	(23 154)	(23 536)	(25 683)	(26 984)	(28 973)	(31 338)	(32 342)	(32 345)	(33 108)	(33 060)	(32 396)	(33 066)	(32 005)	(31 916)	(33 122)	(34 365)	(37 713)	(39 349)	(41 387)	(43 647)	(46 143)	(46 201)	(46 244)	(45 811)	(49 334)	(49 641)	(54 316)	(55 922)	(57 756)	(56 092)	(54 791)	(56 296)	(56 480)	(59 706)	(60 821)	(61 034)	(58 558)	(55 741)	(55 734)	(57 073)	(59 972)	(63 428)	(66 176)	(66 197)	(68 177)	(70 183)	(68 117)	(67 425)	(66 221)	(67 721)	(73 487)	(76 161)	(81 774)	(85 261)	(84 202)	(85 983)	(82 420)	(81 719)	(85 512)	(83 789)	(75 575)	(83 052)	(81 817)	(84 490)	(82 917)	(83 415)	(87 071)	(89 932)	(102 102)	(108 311)	(109 500)	(114 621)	(116 604)	(120 821)	(128 329)	(133 173)	(135 509)	(140 418)	(146 271)	(153 381)	(161 195)	(167 528)	(171 888)	(178 044)
Selling, General & Administrative	(22 649)	(23 009)	(25 100)	(26 386)	(28 379)	(30 657)	(31 668)	(31 688)	(32 024)	(31 377)	(30 724)	(31 405)	(30 883)	(31 381)	(32 641)	(33 726)	(37 037)	(38 860)	(40 884)	(43 344)	(45 826)	(47 049)	(48 080)	(48 703)	(47 196)	(49 117)	(50 678)	(52 852)	(56 521)	(56 953)	(57 710)	(57 614)	(55 481)	(57 943)	(59 109)	(59 878)	(57 525)	(54 699)	(54 644)	(56 006)	(58 985)	(62 390)	(65 607)	(65 559)	(67 371)	(68 463)	(66 402)	(65 736)	(65 464)	(67 054)	(71 204)	(73 815)	(80 974)	(84 210)	(83 011)	(84 714)	(81 447)	(77 256)	(77 464)	(75 416)	(74 045)	(72 746)	(69 664)	(68 842)	(64 021)	(64 002)	(68 043)	(70 626)	(83 329)	(91 384)	(94 842)	(100 579)	(102 182)	(106 009)	(113 203)	(118 380)	(122 101)	(127 189)	(132 542)	(138 951)	(145 347)	(149 531)	(151 320)	(155 928)
Research & Development	(106)	(109)	(154)	(166)	(150)	(255)	(260)	(255)	(690)	(1 304)	(1 314)	(1 321)	(801)	(225)	(174)	(349)	(401)	0	(228)	(15)	(27)	0	0	0	(597)	0	0	0	(865)	0	0	0	(592)	0	0	(592)	(591)	0	0	0	(452)	(66)	0	0	(213)	0	0	0	(104)	(32)	(49)	(65)	(84)	(67)	(72)	(72)	(77)	(3 059)	(6 590)	(6 591)	(116)	(7 394)	(8 438)	(12 492)	(16 993)	(17 405)	(17 789)	(17 768)	(17 328)	(15 523)	(13 243)	(12 613)	(12 957)	(13 384)	(13 290)	(13 045)	(12 255)	(12 124)	(12 334)	(12 256)	(13 259)	(14 936)	(17 331)	(18 914)
Depreciation & Amortization	(398)	(417)	(428)	(431)	(442)	(426)	(414)	(402)	(393)	(379)	(358)	(341)	(321)	(311)	(309)	(290)	(277)	(268)	(275)	(289)	(289)	0	0	0	(438)	0	0	0	(369)	0	0	(50)	(407)	(378)	(489)	(563)	(442)	(451)	(499)	(477)	(535)	(547)	(502)	(571)	(592)	(591)	(617)	(607)	(653)	(636)	(636)	(683)	(715)	(807)	(941)	(1 019)	(896)	(1 009)	(1 065)	(1 388)	(1 415)	(1 358)	(2 160)	(1 680)	(1 903)	(2 086)	(1 317)	(1 539)	(1 446)	(1 404)	(1 415)	(1 428)	(1 465)	(1 427)	(1 327)	(1 240)	(1 154)	(1 105)	(1 395)	(2 109)	(2 589)	(3 062)	(3 237)	(2 983)
Other Operating Expenses	0	0	0	0	(2)	0	0	0	(2)	0	0	0	0	0	0	0	0	(221)	0	0	0	848	1 836	2 892	(1 103)	(524)	(3 638)	(3 070)	0	861	2 919	1 368	0	(1 385)	(1 223)	0	0	(591)	(591)	(590)	0	(425)	(67)	(67)	0	(1 129)	(1 098)	(1 082)	0	0	(1 598)	(1 598)	0	(177)	(178)	(178)	0	(395)	(393)	(394)	0	(1 554)	(1 555)	(1 476)	0	78	78	0	0	0	0	0	0	0	(508)	(508)	0	0	0	(65)	0	0	0	(219)
Operating Income	10 904 N/A	10 289 -6%	12 410 +21%	12 202 -2%	13 978 +15%	13 053 -7%	11 357 -13%	12 718 +12%	10 976 -14%	12 769 +16%	11 884 -7%	11 119 -6%	11 002 -1%	12 014 +9%	14 229 +18%	12 926 -9%	13 047 +1%	12 699 -3%	13 053 +3%	14 420 +10%	16 881 +17%	18 410 +9%	20 018 +9%	21 112 +5%	16 661 -21%	16 856 +1%	12 071 -28%	10 839 -10%	7 238 -33%	10 262 +42%	11 653 +14%	10 237 -12%	5 489 -46%	4 012 -27%	1 989 -50%	3 634 +83%	10 376 +186%	10 475 +1%	12 275 +17%	13 399 +9%	9 801 -27%	8 431 -14%	11 012 +31%	11 894 +8%	12 933 +9%	9 964 -23%	5 264 -47%	1 925 -63%	4 165 +116%	5 878 +41%	6 846 +16%	10 582 +55%	10 403 -2%	8 896 -14%	9 229 +4%	7 315 -21%	15 367 +110%	14 767 -4%	9 287 -37%	8 534 -8%	2 418 -72%	2 315 -4%	4 849 +109%	3 392 -30%	1 976 -42%	687 -65%	(1 622) N/A	(268) +83%	(1 084) -304%	(998) +8%	2 686 N/A	5 920 +120%	9 676 +63%	11 953 +24%	10 718 -10%	6 143 -43%	5 061 -18%	4 394 -13%	5 399 +23%	6 059 +12%	6 701 +11%	9 494 +42%	12 773 +35%	16 730 +31%
Pre-Tax Income
Interest Income Expense	692	712	1 022	2 313	3 344	2 939	2 260	918	672	961	3 163	4 029	2 721	1 794	(1 701)	(4 383)	(7 995)	(6 560)	(1 976)	(148)	3 021	2 221	(150)	(539)	2 702	313	(381)	(476)	1 751	(831)	(729)	301	378	829	20	(594)	(364)	(239)	414	777	891	508	747	86	(433)	(196)	(359)	(292)	39	(487)	(12)	477	981	1 542	1 645	2 220	1 361	1 769	2 304	1 600	1 220	819	(282)	665	2 318	2 121	1 922	1 614	4 997	5 094	4 706	3 710	(2 370)	(2 382)	(1 269)	(192)	(553)	4 811	1 463	(969)	(887)	(7 157)	(4 875)	(3 858)
Non-Reccuring Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(1 159)	0	0	0	0	0	0	(631)	0	0	0	0	107	107	(138)	(138)	(425)	0	(210)	(226)	(1 130)	0	0	0	(1 615)	(1 599)	0	0	(162)	0	0	0	(395)	0	0	0	(1 556)	0	0	0	(2 037)	(2 037)	(2 033)	(2 035)	0	0	(4)	0	(508)	(508)	0	0	(65)	(65)	(65)	0	(220)	(219)	(219)	0
Gain/Loss on Disposition of Assets	(6)	0	0	0	0	0	0	0	(1)	0	(2)	(2)	3	(1)	1	0	(8)	(4)	7	19	35	0	0	0	0	0	0	0	413	0	0	0	0	0	0	0	(1)	0	0	(1)	38	0	0	0	41	37	(84)	(84)	0	0	130	0	9	9	13	23	(32)	16	28	18	25	0	0	0	(60)	0	76	0	139	183	47	31	28	(5)	(4)	25	17	6	13 501	13 928	13 216	13 236	(260)	(700)
Total Other Income	300	353	(1 579)	(1 800)	(2 275)	(2 270)	(446)	(274)	98	(577)	(999)	(868)	(1 020)	(134)	809	757	397	123	(511)	(797)	(1 188)	(1 139)	(1 265)	(1 166)	0	1	0	1	424	638	475	1 656	(1 958)	(2 254)	(2 448)	(3 412)	(1 727)	(4 147)	(4 611)	(5 275)	(3 189)	(461)	510	1 664	213	(57)	(1 114)	(1 964)	(1 028)	(973)	4	245	1 302	2 067	2 119	2 117	65	(501)	(784)	(625)	69	(107)	(1 787)	(2 183)	(1 419)	(1 309)	401	557	(247)	(350)	155	710	549	443	85	(367)	(194)	1 448	1 440	1 441	1 429	(492)	(741)	(656)
Pre-Tax Income	11 890 N/A	11 354 -5%	11 853 +4%	12 715 +7%	15 047 +18%	13 723 -9%	13 170 -4%	13 361 +1%	11 745 -12%	13 151 +12%	14 045 +7%	14 277 +2%	12 707 -11%	13 672 +8%	13 336 -2%	9 299 -30%	5 441 -41%	6 257 +15%	10 572 +69%	13 493 +28%	18 749 +39%	19 492 +4%	18 603 -5%	19 407 +4%	18 204 -6%	17 170 -6%	11 690 -32%	10 364 -11%	9 826 -5%	10 069 +2%	11 399 +13%	11 563 +1%	3 909 -66%	2 587 -34%	(439) N/A	(372) +15%	8 390 N/A	6 195 -26%	7 939 +28%	8 762 +10%	7 117 -19%	8 478 +19%	12 059 +42%	13 418 +11%	11 623 -13%	9 750 -16%	3 708 -62%	(414) N/A	1 561 N/A	2 817 +80%	6 966 +147%	11 304 +62%	12 532 +11%	12 513 0%	13 004 +4%	11 674 -10%	16 366 +40%	16 052 -2%	10 835 -33%	9 529 -12%	2 176 -77%	3 027 +39%	2 779 -8%	1 874 -33%	778 -58%	(538) N/A	(1 256) -134%	(133) +89%	3 805 N/A	3 929 +3%	7 589 +93%	10 371 +37%	7 375 -29%	9 502 +29%	9 530 +0%	5 610 -41%	4 267 -24%	10 594 +148%	21 738 +105%	20 460 -6%	20 239 -1%	14 862 -27%	6 677 -55%	11 517 +72%
Net Income
Tax Provision	(3 195)	(2 759)	(3 523)	(3 699)	(5 338)	(4 974)	(4 331)	(4 368)	(3 516)	(3 903)	(4 049)	(4 294)	(3 954)	(4 298)	(4 232)	(3 013)	(1 599)	(1 088)	(2 669)	(3 972)	(4 770)	(5 566)	(4 136)	(4 428)	(1 876)	(1 508)	(363)	370	(3 176)	(3 232)	(3 366)	(3 312)	(329)	198	249	502	(1 201)	(1 448)	(919)	(1 222)	(7 987)	(7 728)	(9 285)	(9 496)	(2 726)	(2 302)	(1 072)	(142)	(228)	(368)	(1 339)	(1 605)	(4 340)	(4 253)	(4 345)	(4 646)	(3 188)	(3 217)	(2 383)	(2 081)	(34)	(79)	(3 130)	(3 265)	(2 166)	(2 050)	1 678	1 432	(61)	(69)	(782)	(942)	(496)	(1 168)	(1 709)	(1 115)	(3 269)	(4 609)	(6 761)	(6 487)	(3 896)	(2 701)	(1 131)	(2 240)
Income from Continuing Operations	8 695	8 593	8 329	9 015	9 709	8 748	8 839	8 994	8 229	9 250	9 997	9 984	8 753	9 375	9 104	6 286	3 841	5 169	7 904	9 522	13 979	13 926	14 467	14 979	16 328	15 663	11 328	10 735	6 650	6 837	8 033	8 251	3 580	2 784	(192)	128	7 189	4 745	7 019	7 539	(870)	750	2 774	3 922	8 897	7 448	2 636	(556)	1 333	2 451	5 630	9 703	8 192	8 262	8 660	7 027	13 178	12 835	8 452	7 450	2 142	2 948	(352)	(1 393)	(1 388)	(2 590)	421	1 298	3 744	3 860	6 807	9 428	6 879	8 334	7 821	4 495	998	5 985	14 977	13 974	16 343	12 161	5 546	9 276
Income to Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	36	0	0	0	(180)	(140)	(164)	(652)	(55)	(180)	(172)	128	(483)	(401)	(322)	(55)	69	362	397	438	467	478	389	371	382	250	256	138	(33)	(54)	(20)	83	42	28	73	(33)	394	392	567	390	73	84	(179)	92	196	217	198	43	(4)	(35)	(20)	86	292	421	372	308	502	471	558	603
Net Income (Common)	8 695 N/A	8 593 -1%	8 329 -3%	9 015 +8%	9 709 +8%	8 748 -10%	8 839 +1%	8 994 +2%	8 229 -9%	9 250 +12%	9 997 +8%	9 984 0%	8 753 -12%	9 375 +7%	9 104 -3%	6 286 -31%	3 841 -39%	5 169 +35%	7 904 +53%	9 522 +20%	13 979 +47%	13 926 0%	14 467 +4%	14 979 +4%	16 364 +9%	15 699 -4%	11 364 -28%	10 771 -5%	6 470 -40%	6 517 +1%	7 689 +18%	7 418 -4%	3 625 -51%	2 672 -26%	(355) N/A	266 N/A	6 525 +2 353%	4 087 -37%	5 948 +46%	6 735 +13%	(1 368) N/A	561 N/A	3 171 +465%	4 360 +37%	9 364 +115%	7 926 -15%	3 025 -62%	(185) N/A	1 715 N/A	2 700 +57%	5 885 +118%	9 840 +67%	8 159 -17%	8 210 +1%	8 641 +5%	7 111 -18%	13 220 +86%	12 862 -3%	8 524 -34%	7 416 -13%	2 536 -66%	3 338 +32%	215 -94%	(1 003) N/A	(1 315) -31%	(2 504) -90%	243 N/A	1 391 +474%	3 939 +183%	4 077 +4%	7 005 +72%	9 471 +35%	6 875 -27%	8 298 +21%	7 801 -6%	4 581 -41%	1 290 -72%	6 406 +397%	15 349 +140%	14 281 -7%	16 845 +18%	12 632 -25%	6 103 -52%	9 879 +62%
EPS (Diluted)	790.45 N/A	781.18 -1%	757.18 -3%	819.54 +8%	882.63 +8%	874.8 -1%	883.9 +1%	899.4 +2%	822.9 -9%	925 +12%	999.7 +8%	998.4 0%	875.3 -12%	937.5 +7%	910.4 -3%	628.6 -31%	384.1 -39%	430.75 +12%	878.22 +104%	952.2 +8%	1 397.9 +47%	1 392.6 0%	1 446.7 +4%	1 497.9 +4%	1 636.4 +9%	1 427.18 -13%	1 033.09 -28%	979.18 -5%	588.18 -40%	592.45 +1%	1 281.5 +116%	1 236.33 -4%	329.54 -73%	267.2 -19%	-35.5 N/A	33.25 N/A	652.5 +1 862%	371.54 -43%	540.72 +46%	612.27 +13%	-124.36 N/A	46.75 N/A	243.92 +422%	396.36 +62%	780.33 +97%	720.54 -8%	252.08 -65%	-15.41 N/A	155.9 N/A	225 +44%	490.41 +118%	820 +67%	679.91 -17%	684.16 +1%	720.08 +5%	592.58 -18%	1 101.66 +86%	1 169.27 +6%	774.9 -34%	674.18 -13%	230.54 -66%	303.45 +32%	19.54 -94%	-91.18 N/A	-119.54 -31%	-218.52 -83%	21.16 N/A	121.42 +474%	343.93 +183%	355.82 +3%	615.94 +73%	833.27 +35%	604.21 -27%	730.14 +21%	686.35 -6%	403.1 -41%	113.51 -72%	563.64 +397%	1 350.51 +140%	1 256.56 -7%	1 482.18 +18%	1 111.44 -25%	537.02 -52%	869.22 +62%

Income Statement Balance Sheet Cash Flow Statement

Ahn-Gook Pharmaceutical Co Ltd
KOSDAQ:001540

Income Statement

Earnings Waterfall
Ahn-Gook Pharmaceutical Co Ltd

Income Statement
Ahn-Gook Pharmaceutical Co Ltd

See Also

Company

Help

Tools

Stocks

Ahn-Gook Pharmaceutical Co Ltd KOSDAQ:001540

Income Statement

Earnings Waterfall Ahn-Gook Pharmaceutical Co Ltd

Income Statement Ahn-Gook Pharmaceutical Co Ltd

See Also

Company

Help

Tools

Stocks

Ahn-Gook Pharmaceutical Co Ltd
KOSDAQ:001540

Earnings Waterfall
Ahn-Gook Pharmaceutical Co Ltd

Income Statement
Ahn-Gook Pharmaceutical Co Ltd